See the notice on TED website
1. Buyer
1.1.
Buyer
Official name: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego
Legal type of the buyer: Body governed by public law
Activity of the contracting authority: Health
2. Procedure
2.1.
Procedure
Title: Zakup i dostawa produktów leczniczych stosowanych w ramach programów lekowych, chemioterapii oraz poza programami.
Description: 1. Przedmiotem zamówienia jest sukcesywna dostawa produktów leczniczych stosowanych w ramach programów lekowych, chemioterapii oraz poza programami w podziale na 28 części z dostawą do trzech lokalizacji UCK WUM: - Apteki UCK WUM CSK przy ul. Nielubowicza 5, 02-097 Warszawa - Apteki UCK WUM DSK przy ul. Żwirki i Wigury 63a, 02-091 Warszawa - Apteki UCK WUM SKDJ przy ul. Lindleya 4, 02-005 Warszawa 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Procedure identifier: 11ba83ca-cf48-4ecd-b3ce-b392c890f965
Internal identifier: DZPUCK.262.131.2026
Type of procedure: Open
The procedure is accelerated: no
2.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
2.1.2.
Place of performance
Postal address: UCK WUM
Town: Warszawa
Postcode: 02-097
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
Additional information: Wykonawca jest zobowiązany do dostarczania przedmiotu zamówienia, zgodnie ze wskazaniem w zamówieniu jednostkowym, do: - Apteki UCK WUM DSK, ul. Żwirki i Wigury 63a, 02-091 Warszawa - Apteki UCK WUM CSK, ul. Nielubowicza 5, 02-097 Warszawa - Apteki UCK WUM SKDJ, ul. Lindleya 4, 02-005 Warszawa
2.1.4.
General information
Additional information: 1. Niniejsze postępowanie o udzielenie zamówienia publicznego prowadzone w trybie przetargu nieograniczonego, na podstawie art. 132 ustawy. 2. Zamawiający nie wymaga wniesienia wadium na przedmiotowe postępowanie. 3. Zamawiający nie żąda od Wykonawcy, którego oferta została wybrana wniesienia przed zawarciem umowy zabezpieczenia należytego wykonania umowy. 4. Podstawy wykluczenia Wykonawcy z postępowania wnikające z art. 108 ust. 1 oraz art. 109 ust. 1 pkt 4, 7, 8, 9 i 10 ustawy pzp oraz przepisy ustawy z dnia 13 kwietnia 2022 r. o szczególnych rozwiązaniach w zakresie przeciwdziałania wspieraniu agresji na Ukrainę oraz służących ochronie bezpieczeństwa narodowego oraz Rozporządzenia Rady (UE) Nr 833/2014 z dnia 31 lipca 2014 r. dotyczącego środków ograniczających w związku z działaniami Rosji destabilizującymi sytuację na Ukrainie Zamawiający szczegółowo określił w Rozdziale VI SWZ PODSTAWY WYKLUCZENIA WYKONAWCY Z POSTĘPOWANIA. 5. Wraz z ofertą Wykonawca zobowiązany jest złożyć: oświadczenie, że Wykonawca nie podlega wykluczeniu oraz spełnia warunki określone w SWZ, zwane dalej „JEDZ” oraz przedmiotowe środki dowodowe określone w Rozdziale VII SWZ. 6. Zamawiający przed wyborem najkorzystniejszej oferty wezwie Wykonawcę, którego oferta została najwyżej oceniona, do złożenia w wyznaczonym terminie, nie krótszym niż 10 dni, aktualnych na dzień złożenia podmiotowych środków dowodowych, o których mowa w Rozdziale VIII SWZ. 7. Dokumentem tymczasowo zastępującym podmiotowe środki dowodowe, o których mowa ust. 6 potwierdzającym brak podstaw wykluczenia z postępowania, na dzień składania ofert, jest oświadczenie, którego treść odpowiada zakresowi oświadczenia, o którym mowa w art. 125 ust. 1 ustawy, składane na druku formularza jednolitego europejskiego dokumentu zamówienia „JEDZ”, sporządzonego zgodnie ze wzorem standardowego formularza określonego w rozporządzeniu Wykonawczym Komisji (UE) 2016/7 z dnia 5 stycznia 2016 r. ustanawiającym standardowy formularz jednolitego europejskiego dokumentu zamówienia, zwanego dalej „jednolitym dokumentem”, którego wzór stanowi Załącznik nr 5 do SWZ. Oświadczenie należy złożyć wraz z ofertą. Dokumentem potwierdzającym brak podstaw wykluczenia z postępowania na podstawie okoliczności określonych w art. 5k rozporządzenia Rady (UE) 833/2014 z dnia 31 lipca 2014 r. dotyczącego środków ograniczających w związku z działaniami Rosji destabilizującymi sytuację na Ukrainie w brzmieniu nadanym rozporządzeniem Rady (UE) 2022/576 z dnia 8 kwietnia 2022 r. w sprawie zmiany rozporządzenia (UE) nr 833/2014 dotyczącego środków ograniczających w związku z działaniami Rosji destabilizującymi sytuację na Ukrainie, jest oświadczenie, którego wzór stanowi Załącznik nr 8 do SWZ. Oświadczenie należy złożyć wraz z ofertą. 8. W prowadzonym postępowaniu, w oparciu o art. 139 ust. 1 ustawy, Zamawiający najpierw dokona badania i oceny ofert, a następnie dokona kwalifikacji podmiotowej Wykonawcy, którego oferta została najwyżej oceniona, w zakresie braku podstaw wykluczenia oraz spełniania warunków udziału w postępowaniu. 9. Dokumenty w języku obcym składane są wraz z tłumaczeniem na język polski. 10. Komunikacja w postępowaniu o udzielenie zamówienia w tym składanie ofert, wymiana informacji oraz przekazywanie dokumentów lub oświadczeń między zamawiającym a wykonawcą, z uwzględnieniem wyjątków określonych w ustawie, odbywa się przy użyciu środków komunikacji elektronicznej, tj. przy użyciu Platformy zakupowej „ezamawiający”, zgodnie z informacją zawartą w Rozdziale II pkt. 4, z zastrzeżeniem postanowień pkt. 5. 11. Jeżeli Wykonawca nie złoży wraz z ofertą przedmiotowych środków dowodowych lub złożone przedmiotowe środki dowodowe są niekompletne, Zamawiający wezwie do ich złożenia lub uzupełnienia w wyznaczonym terminie.
Legal basis:
Directive 2014/24/EU
2.1.5.
Terms of procurement
Terms of submission:
Maximum number of lots for which one tenderer can submit tenders: 28
Terms of contract:
Maximum number of lots for which contracts can be awarded to one tenderer: 28
2.1.6.
Grounds for exclusion
Sources of grounds for exclusion: Procurement Document
5. Lot
5.1.
Lot: LOT-0001
Title: Część nr 1
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 1
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0002
Title: Część nr 2
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 2
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0003
Title: Część nr 3
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 3
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0004
Title: Część nr 4
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 4
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0005
Title: Część nr 5
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 5
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0006
Title: Część nr 6
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 6
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0007
Title: Część nr 7
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 7
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0008
Title: Część nr 8
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 8
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0009
Title: Część nr 9
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 9
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0010
Title: Część nr 10
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 10
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0011
Title: Część nr 11
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 11
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0012
Title: Część nr 12
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 12
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0013
Title: Część nr 13
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 13
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0014
Title: Część nr 14
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 14
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0015
Title: Część nr 15
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 15
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0016
Title: Część nr 16
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 16
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0017
Title: Część nr 17
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 17
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0018
Title: Część nr 18
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 18
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0019
Title: Część nr 19
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 19
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0020
Title: Część nr 20
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 20
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0021
Title: Część nr 21
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 21
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0022
Title: Część nr 22
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 22
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0023
Title: Część nr 23
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 23
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 6 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0024
Title: Część nr 24
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 24
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0025
Title: Część nr 25
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 25
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0026
Title: Część nr 26
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 26
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0027
Title: Część nr 27
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 27
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
5.1.
Lot: LOT-0028
Title: Część nr 28
Description: 2. Szczegółowy opis przedmiotu zamówienia stanowi Załącznik nr 2 do SWZ - Formularz asortymentowo-cenowy (odpowiednio w zakresie Części, której dotyczy).
Internal identifier: 28
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Town: Warszawa
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
5.1.3.
Estimated duration
Duration: 12 Months
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.10.
Award criteria
Criterion:
Type: Price
Description: cena 100%
Category of award weight criterion: Weight (percentage, exact)
Award criterion number: 100
5.1.11.
Procurement documents
Languages in which the procurement documents are officially available: Polish
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: Polish
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 24/08/2026 10:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 90 Days
Information about public opening:
Opening date: 24/08/2026 10:30:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Place: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Dział Zamówień Publicznych, ul. Banacha 1a, 02-097 Warszawa, blok A, POLSKA za pośrednictwem Platformy prowadzonego postępowania ezamawiający.
Additional information: Termin związania ofertą do 21.11.2026
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: yes
Electronic payment will be used: yes
5.1.15.
Techniques
Framework agreement:
No framework agreement
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Krajowa Izba Odwoławcza
Information about review deadlines: Informacje dot. składania odwołań zawarte są w Rozdziale XXI SWZ.
8. Organisations
8.1.
ORG-0001
Official name: Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego
Registration number: 5220002529
Postal address: ul. Banacha 1a
Town: Warszawa
Postcode: 02-097
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
Contact point: Osoba prowadząca postępowanie:
Telephone: 22599170
Fax: 225991704
Roles of this organisation:
Buyer
8.1.
ORG-0002
Official name: Krajowa Izba Odwoławcza
Registration number: 5262239325
Postal address: ul. Postępu 17 a
Town: Warszawa
Postcode: 02-676
Country subdivision (NUTS): Miasto Warszawa (PL911)
Country: Poland
Telephone: 224587801
Roles of this organisation:
Review organisation
8.1.
ORG-0000
Official name: Publications Office of the European Union
Registration number: PUBL
Town: Luxembourg
Postcode: 2417
Country subdivision (NUTS): Luxembourg (LU000)
Country: Luxembourg
Telephone: +352 29291
Roles of this organisation:
TED eSender
Notice information
Notice identifier/version: fad937e8-2310-4255-8bef-b45458022df3 - 01
Form type: Competition
Notice type: Contract or concession notice – standard regime
Notice subtype: 16
Notice dispatch date: 23/07/2026 10:10:16 (UTC+00:00) Western European Time, GMT
Languages in which this notice is officially available: Polish
Notice publication number: 519658-2026
OJ S issue number: 143/2026
Publication date: 28/07/2026